Amsterdam, 15 November 2022 – Teledyne DALSA, a Teledyne Technologies company and global leader in Digital X-Ray Image Sensing technology, is pleased to announce it has acquired the Sigmascreening B.V. patents and IP portfolio on pressure-sensitive breast compression for screening. With its purchase, Teledyne DALSA has exclusive access to the Sigmascreening IP portfolio and algorithms. Holland Capital was one of the early investors in Sigmascreening.
Unique combination
The unique combination of detector and pressure-sensitive compression is expected to create new possibilities for immediate diagnostic information as well as biomarkers for breast screening. According to Thorsten Achterkirchen, Vice President and General Manager of Teledyne DALSA’s X-Ray Solutions business, “We intend to expand our CMOS X-Ray detector product line for mammography and digital breast tomosynthesis (DBT) with new subsystem products for optimizing breast imaging and improving patient comfort during mammographic screening.”
Ivo Aarninkhof, CEO of Sigmascreening, says that ‘’We are delighted with the purchase of the Sigmascreening patents and IP portfolio by Teledyne DALSA. Use of the pressure-based compression during digital breast tomosynthesis and mammography improves participant and technologist experience and reduces compression pressure variability, mean breast thickness, and glandular dose.”1
Expertise in radiology
Holland Capital joined the company in 2014 as an early investor. The investment has been used for product development and commercial growth in recent years. Holland Capital is experienced in supporting innovative radiology solutions. This is the investor’s second exit in the field of medical imaging, following the acquisition of Quantib, a leading radiology artificial intelligence (“AI”) company, by RadNet Inc earlier this year.
Jan-Frens van Giessel, Partner Holland Capital : “We are proud that we have been able to assist Sigmascreening in the past 8 years. Sigmascreening’s pressure sensitive breast compression reduces extreme pain during mammography and improves detection of breast cancer. It is great to see that this important healthcare innovation will become available for women worldwide with the acquisition of Teledyne DALSA.”
About Teledyne DALSA
Teledyne DALSA provides state-of-the-art image sensing, capture and processing solutions to medical, dental, and scientific equipment manufacturers. Building on more than 30 years of proven capability and innovation, our highly skilled team of imaging specialists adds value with their continued focus on leading-edge product design. Our manufacturing processes are tailored to comply with the stringent quality, reliability, and traceability requirements of the medical and scientific X-ray community.
About Sigmascreening
Sigmascreening B.V. is a medical device company focusing on the development of new innovative products in the area of digital mammography and breast cancer screening. Sigmascreening was established as a spin-off company from the Amsterdam UMC.
About Holland Capital
Over the past 40 years, Holland Capital has responsibly and successfully invested in over more than 150 SME-companies. With a clear investment strategy Holland Capital is active in the attractive growth markets of Healthcare and Technology. Holland Capital’s experienced and committed investment team understand entrepreneurship. They aim to establish an open, sustainable, and professional relationship with the companies they invest in, with the common goal of achieving growth. Holland Capital is backed by a broad network of successful Healthcare and Technology entrepreneurs.
1 quote is based on this scientific article: https://academic.oup.com/jbi/advance-article/doi/10.1093/jbi/wbaa070/5902745
Kids Lodge neemt BSO Wijs! over
Kids Lodge neemt BSO Wijs! over Amsterdam/ Houten, 21 maart 2024 - Ons portfoliobedrijf Kids Lodge neemt kinderopvangorganisatie BSO Wijs! over. Door de overname breidt Kids Lodge haar kinderopvang activiteiten in de regio Utrecht verder uit. BuitenSpeelOpvang (BSO)...
Holland Capital haalt na korte en succesvolle fundraise een nieuw private equity fonds van EUR 225 miljoen op
Holland Capital haalt na korte en succesvolle fundraise een nieuw private equity fonds van EUR 225 miljoen op Amsterdam/ Düsseldorf, 5 maart 2024 - Na een fundraise periode van vijf maanden heeft Holland Capital haar nieuwe investeringsfonds Holland Capital Growth...
Vacature: Office Manager
Wij zijn per 1 mei 2024 (i.v.m. zwangerschapsverlof) op zoek naar een representatieve, enthousiaste office manager, die het uitdagend vindt om in een dynamische omgeving te werken.
Complementair duo op de sofa
Managing partners Hubert Verbeek en Ewout Prins leren andere ondernemers het liefst kennen via ‘sofasessies’. Laagdrempelige sessies waarin vooral persoonlijke vragen gesteld worden. Voor het eerst in het 40-jarig bestaan van Holland Capital nemen ze nu zelf plaats op de sofa.
Holland Capital investeert in de groeiambities van Adjust
Holland Capital investeert in de groeiambities van Adjust Amsterdam/ Amstelveen, 23 januari 2024 - Holland Capital investeert in Adjust, een gerenommeerd inkoop- en contractmanagement adviesbureau voor de publieke, semipublieke en private sector. De investering van...
Emixa kondigt rebranding van gelieerde bedrijven aan
Emixa kondigt rebranding van gelieerde bedrijven aan Naarden, 8 januari 2024 - Ons portfoliobedrijf Emixa, de toonaangevende partner voor digitale transformatie, kondigt de rebranding aan van zijn gelieerde bedrijven onder de Emixa merknaam in de Benelux en het VK. De...
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 311 94 11
Düsseldorf
Inselstraße 34
40479 Düsseldorf
+49 (0) 211 43 63 69 01
Contact
info@hollandcapital.nl